TMDX Trading Analysis - 11/06/2026 05:38 PM — TRU-SENTIMENT

TMDX (TransMedics Group Inc. Common Stock) at $88.30. True Sentiment Bullish, delta 40-60 call 73% / put 27%, call $2,017,220 vs put $730,905. RSI 69.5.

TRU-SENTIMENT · DeltaNeutral

TMDX Trading Analysis - 11/06/2026 05:38 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

TMDX (TransMedics Group Inc. Common Stock) at $88.30. True Sentiment Bullish, delta 40-60 call 73% / put 27%, call $2,017,220 vs put $730,905. RSI 69.5.

Symbol
TMDX
Price
$88.30
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-06 17:38:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Options flow via True Sentiment (Delta 40-60 only):

Call Dollar Volume: $2,017,220 (73.4%) Put Dollar Volume: $730,905 (26.6%) Total: $2,748,125

Call contracts: 3,313 vs put contracts: 265. Sentiment: Bullish. Pure directional conviction strongly favors calls, suggesting near-term upside expectations. Divergence: technicals show MACD negative and spread engine flagged "Divergence detected between technical indicators and options sentiment" — options bullish, technicals lack clear direction.

Key Statistics: TMDX

$88.24 +28.11%
52-Week Range
$60.10 - $156.00
Market Cap
$3.06B
P/E (TTM)
15.60
PEG Ratio
N/A
Beta
2.84
Next Earnings
N/A
Avg Volume
$598,379
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)15.60
EPS (trailing 12 mo)$4.43
Market cap$3.06B
Shares outstanding34.7M

Dividend

Dividend yield0.00%

Risk & range

Beta2.84
52-week low$60.10
52-week high$156.00
Historical volatility51.7%

Ownership & trading

Institutional ownership74.0%
Average daily volume1.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context:

TransMedics Group (TMDX) is a medical technology company focused on organ transplant systems. Based on general knowledge (not embedded data), recent relevant context includes:

  • TransMedics continued to scale its Organ Care System (OCS) platform with growing adoption in heart and lung transplant centers through 2025–2026.
  • Prior quarterly results showed strong revenue growth but ongoing scrutiny over transplant logistics and reimbursement dynamics.
  • No specific confirmed earnings date is available in this analysis, but a fiscal year-end of 2025-12-01 suggests annual reporting cycles may introduce volatility.
  • Possible catalyst: increased transplant volume and hospital utilization could support bullish positioning, aligning with the embedded options sentiment.
  • Context: The strong call flow in the embedded data may reflect optimism around continued procedural growth rather than a confirmed near-term event.

Fundamental Analysis:

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E: 15.60; Trailing EPS: $4.43 — relatively low multiple vs high-growth med-tech peers.
  • Market Cap: $3.06B; Shares Outstanding: 34.68M; Institutional Ownership: 74.01%.
  • 52-Week Range: $60.11 to $156.00 — current price ($88.17) sits in the lower half of the annual range.
  • Beta: 2.84 — high systemic risk and sensitivity to broad market moves.
  • Dividend Yield: 0.00% — no income component.
  • PEG Ratio, Forward P/E, Revenue Growth, Margins, ROE, Debt/Equity, and FCF are null — cannot be assessed from data.
  • Analyst target mean price and consensus are null — no external analyst context provided.
  • Fundamentals show a cheap earnings multiple and strong institutional base, but lack of margin/growth data creates a partial picture that diverges from the sharp technical rally and bullish options flow.

Current Market Position:

Current price from indicators: $88.17 (2026-11-06 close). Daily history shows a powerful move from $67.21 (2026-11-02) to $88.17 on 2026-11-06, a +31.2% weekly surge. Volume on 2026-11-06 was 2,380,263 vs 20-day avg of 738,775 — confirmation of breakout participation.

Minute bars (2026-11-05 open $72.49 → 2026-11-06 15:55 close $88.30) show steady intraday accumulation with late-session volume spikes (209,039 at final bar). Price held above $87.77 intraday, indicating sustained momentum into close.

Technical Analysis:

Technical Indicators

Current Price
$88.17
SMA 5
$72.82
SMA 20
$72.29
SMA 50
$79.61
RSI 14
69.47
MACD
-1.77
Signal
-1.42
Histogram
-0.35
Bollinger Mid
$72.29
Bollinger Up
$82.67
Bollinger Low
$61.91
ATR 14
$5.04
30D High
$88.44
30D Low
$64.64

Price is above SMA 5 ($72.82), SMA 20 ($72.29), and SMA 50 ($79.61) — bullish alignment with price extended above all averages. RSI at 69.47 approaches overbought but remains under 70. MACD is negative (-1.77) with histogram -0.35, showing bearish momentum structure despite price gains (divergence). Bollinger Bands show price ($88.17) above upper band ($82.67) — expansion breakout. 30-day range: price at $88.17 is near the high ($88.44), indicating strength but proximity to local ceiling.

True Sentiment Analysis (Delta 40-60 Options):

Options flow via True Sentiment (Delta 40-60 only):

Call Dollar Volume: $2,017,220 (73.4%) Put Dollar Volume: $730,905 (26.6%) Total: $2,748,125

Call contracts: 3,313 vs put contracts: 265. Sentiment: Bullish. Pure directional conviction strongly favors calls, suggesting near-term upside expectations. Divergence: technicals show MACD negative and spread engine flagged "Divergence detected between technical indicators and options sentiment" — options bullish, technicals lack clear direction.

Key Price Levels (observational only):

30D High
$88.44
SMA 50
$79.61
SMA 5
$72.82
Bollinger Upper (prior ceiling)
$82.67
Next Call Strike (Dec)
$95.00

Interactive charts load with JavaScript. This text is the crawlable summary.